ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone510-279-4262
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees162
Next Earnings Date8/14/2019 (Estimated)
OptionableNot Optionable
Shockwave Medical (NASDAQ:SWAV) Frequently Asked Questions
What is Shockwave Medical's stock symbol?
Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."
How were Shockwave Medical's earnings last quarter?
Shockwave Medical Inc (NASDAQ:SWAV) issued its quarterly earnings results on Wednesday, May, 8th. The company reported ($1.37) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.52) by $0.85. The company earned $7.27 million during the quarter. View Shockwave Medical's Earnings History.
When is Shockwave Medical's next earnings date?
What price target have analysts set for SWAV?
3 equities research analysts have issued twelve-month price objectives for Shockwave Medical's shares. Their forecasts range from $32.00 to $37.00. On average, they anticipate Shockwave Medical's share price to reach $34.00 in the next year. This suggests that the stock has a possible downside of 41.6%. View Analyst Price Targets for Shockwave Medical.
What is the consensus analysts' recommendation for Shockwave Medical?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Shockwave Medical.
Has Shockwave Medical been receiving favorable news coverage?
Press coverage about SWAV stock has been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Shockwave Medical earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days.
Who are some of Shockwave Medical's key competitors?
Some companies that are related to Shockwave Medical include Hill-Rom (HRC), Insulet (PODD), Haemonetics (HAE), Penumbra (PEN), Novocure (NVCR), ICU Medical (ICUI), Integra Lifesciences (IART), Globus Medical (GMED), Tandem Diabetes Care (TNDM), NuVasive (NUVA), Merit Medical Systems (MMSI), Cantel Medical (CMD), Glaukos (GKOS), Nevro (NVRO) and Irhythm Technologies (IRTC).
What other stocks do shareholders of Shockwave Medical own?
Who are Shockwave Medical's key executives?
Shockwave Medical's management team includes the folowing people:
- Mr. Douglas E. Godshall, CEO, Pres & Director (Age 54)
- Mr. Daniel Puckett, CFO & Sec. (Age 55)
- Mr. Isaac Zacharias, Chief Commercial Officer (Age 44)
- Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 52)
- Mr. John M. Adams, Co-Founder and Technical Advisor (Age 72)
When did Shockwave Medical IPO?
(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.
When did Shockwave Medical's quiet period expire?
Shockwave Medical's quiet period expired on Tuesday, April 16th. Shockwave Medical had issued 5,700,000 shares in its public offering on March 7th. The total size of the offering was $96,900,000 based on an initial share price of $17.00. During Shockwave Medical's quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.
Who are Shockwave Medical's major shareholders?
Shockwave Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (13.25%), Gilder Gagnon Howe & Co. LLC (4.76%), JPMorgan Chase & Co. (1.23%), Redmile Group LLC (1.07%), Morgan Stanley (0.83%) and Perceptive Advisors LLC (0.54%). View Institutional Ownership Trends for Shockwave Medical.
Which major investors are buying Shockwave Medical stock?
SWAV stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Gilder Gagnon Howe & Co. LLC, JPMorgan Chase & Co., Redmile Group LLC, Morgan Stanley, Perceptive Advisors LLC, Perceptive Advisors LLC and Goldman Sachs Group Inc.. View Insider Buying and Selling for Shockwave Medical.
How do I buy shares of Shockwave Medical?
Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Shockwave Medical's stock price today?
One share of SWAV stock can currently be purchased for approximately $58.24.
How big of a company is Shockwave Medical?
Shockwave Medical has a market capitalization of $1.63 billion. Shockwave Medical employs 162 workers across the globe.
What is Shockwave Medical's official website?
How can I contact Shockwave Medical?
Shockwave Medical's mailing address is 48501 WARM SPRINGS BLVD. STE. 108, FREMONT CA, 94539. The company can be reached via phone at 510-279-4262 or via email at [email protected]
MarketBeat Community Rating for Shockwave Medical (NASDAQ SWAV)
MarketBeat's community ratings are surveys of what our community members think about Shockwave Medical and other stocks. Vote "Outperform" if you believe SWAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SWAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
